Searchable abstracts of presentations at key conferences in endocrinology

ea0081p165 | Pituitary and Neuroendocrinology | ECE2022

Effects of the SGLT2-inhibitor empagliflozin in patients with chronic syndrome of inadequate antidiuresis (SIAD) - results of a double-blind, randomized, placebo-controlled, crossover trial

Refardt Julie , Imber Cornelia , Nobbenhuis Rianne , Clara Odilia Sailer , Haslbauer Aaron , Vogt Deborah , Berres Manfred , Winzeler Bettina , Bridenbaugh Stephanie , Mirjam Christ-Crain

Introduction: Hyponatremia is the most common electrolyte disorder and the syndrome of inappropriate antidiuresis (SIAD) is one of its main causes. However, treatment options for chronic SIAD-induced hyponatremia are inadequate. This is problematic because hyponatremia has been associated with neurocognitive deficits, although there is little data on its reversibility. We previously showed that the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin is a promising s...